Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.

about

Clinicopathologic features, management and outcomes of blastoid variant of mantle cell lymphoma: a Nebraska Lymphoma Study Group Experience.CCND1-IGH Fusion-Amplification and MYC Copy Number Gain in a Case of Pleomorphic Variant Mantle Cell Lymphoma.

P2860

Q41350868-92D7CBDC-474C-47D2-83C0-C1445D809E90 Q51232550-E612A8B3-8FEA-46FA-9B07-D2EAD4270740

P2860

Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.

Item

http://www.wikidata.org/entity/Q38369665

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.

@en

type

Item

label

Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.

@en

prefLabel

Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.

@en

P1476

Clinicopathologic features and management of blastoid variant of mantle cell lymphoma

@en

P2093

Guru Subramanian Guru Murthy

http://www.w3.org/2001/XMLSchema#string

Rajesh Shrestha

http://www.w3.org/2001/XMLSchema#string

P2860

Nuclear expression of the non B-cell lineage Sox11 transcription factor identifies mantle cell lymphoma

Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics.

Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma.

Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma

FTY720 increases CD74 expression and sensitizes mantle cell lymphoma cells to milatuzumab-mediated cell death.

Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.

Untreated aggressive mantle cell lymphoma: results with intensive chemotherapy without stem cell transplant in elderly patients.

Evaluation of the (R)VAD+C regimen for the treatment of newly diagnosed mantle cell lymphoma. Combined results of two prospective phase II trials from the French GOELAMS group

Combination of rituximab, bendamustine, and cytarabine for patients with mantle-cell non-Hodgkin lymphoma ineligible for intensive regimens or autologous transplantation.

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

P304

2759-2767

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/10428194.2015.1026902

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Vijaya Raj Bhatt

James O Armitage

P577

2015-03-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25747972

http://www.w3.org/2001/XMLSchema#string

Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.

about

P2860

P2860

Clinicopathologic features and management of blastoid variant of mantle cell lymphoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698